In pulmonary fibrosis, the TGFβ1-SMAD pathway is often overactivated, leading to enhanced fibroblast proliferation, myofibroblast differentiation, and ECM production, which collectively contribute to the fibrotic changes observed in the disease. Here, TGFB1 is linked to pulmonary fibrosis.